Vancomycin-resistant enterococci in Canada: Results from the Canadian nosocomial infection surveillance program, 1999-2005

Infection Control and Hospital Epidemiology

Volumn 29, Issue 3, 2008, Pages 271-274

  Ofner Agostini, Marianna ^a   Johnston, B Lynn ^d   Simor, Andrew E ^b   Embil, John ^e   Matlow, Anne ^c   Mulvey, Michael ^f   Ormiston, Debbie ^h   Conly, John ^g  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^e HEALTH SCIENCES CENTRE   (Canada)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^g FOOTHILLS HOSPITAL   (Canada)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; CANADA; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; SCREENING; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CANADA; CARRIER STATE; CROSS INFECTION; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INCIDENCE; SENTINEL SURVEILLANCE; VANCOMYCIN RESISTANCE;

EID: 39449136234     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/528812     Document Type: Article

References (9)

1. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348:1242-1247.
2. Ofner-Agostini ME, Conly J, Paton S, et al. Vancomycin-resistant enterococci (VRE) in Canada - results of the Canadian Nosocomial Infection Surveillance Program 1996: VRE point prevalence surveillance project. Can J Infect Dis 1997; 8:73-78.
3. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1990- May 1999, issued June 1999. Am J Infect Control 1999; 27:520-532.
4. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140.
5. Ofner-Agostini M, Varia M, Johnston L, et al. Infection control and antimicrobial restriction practices for antimicrobial resistant organisms (AROs) in Canadian tertiary care hospitals. Am J Infect Control 2007; 35:563-568.
6. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-386.
7. Simor AE, Ofner-Agostini M, Gravel D, et al.; Canadian Hospital Epidemiology Committee; Canadian Nosocomial Infection Surveillance Program, Public Health Agency of Canada. Surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals - a report update from the Canadian Nosocomial Infection Surveillance Program. Can Commun Dis Rep 2005; 31:33-40. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/ 05pdf/cdr3103.pdf. Accessed January 28, 2008.
8. Johnston BL, Conly JM. Clostridium difficile: the evolving story. Can J Infect Dis Med Microbiol 2007; 18:341-345.
9. Johnston L, Ofner-Agostini ME, Holton D, et al. Laboratory and infection control protocols for vancomycin-resistant enterococci (VRE): a survey of CHEC facilities. In: 67th Conjoint Meeting on Infectious Diseases; October 31-November 4, 1999; Edmonton, Alberta, Canada. Abstract P49.